- Home >
- Life Sciences >
- Medical Devices >
- Diagnostics >
- In Vitro Diagnostic >
In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q3 2009 Edition]
In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q3 2009 Edition]
![In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q3 2009 Edition]](/public/images/pub/1346_big.gif)
- Report price : $ 599
- Publication date : September 2009
In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q3 2009 Edition]
The just published In-Vitro Diagnostic Substance Manufacturing Industry report is the comprehensive market research guide on the industry. Its provides the latest information on the industry's key financial data, competitive landscape, cost and pricing, and trends during the current economic recession.
At 174 pages with over 150 charts and tables, the report's extensive coverage includes a range of topics such as macroeconomic conditions, granular data on products, international trade, channel mix, government demand, and labor structure. Most importantly, it relies on 10 years of historical data and enhanced forecasting to project industry trends up to 2013 about the domestic market, global market and overseas growth opportunities. Industry analysts and Fortune 500 customers consider this quarterly report essential to staying informed about the industry.
In this report, you will find industry data on the following major categories:
Executive Summary
Quick Industry Statistics: 2-page overview for the CEO on the run
Supply & Demand with Capacity Utilization
2009 Outlook
2009-2013 Forecast
Industry Income Statement
All relevant financial data including: Revenue, Cost of Materials, Labor Costs, Gross Profit, SG&A, Net Income, etc.
4-year Financials Comparison and Trends
Industry Balance Sheet
Traditional key elements of Assets, Liabilities, and Equity
Inventory fabrication stages
Calculated balance sheet ratios
Capital Expenditure
Plant additions and expansions
Computer and IT investments
Machinery and Equipment for production and material handling
Industry Cost Analysis
Upstream Industries and the cost allocations towards producer, wholesale, retail, and freight
Materials and their percentage share of total material costs
Industry Pricing Analysis
Producer Pricing Indices at industry, wholesale, and retail levels for comparison and trend forecasting
Pricing Distribution among Downstream Industries differentiated at producer, wholesale, retail, and freight categories
Industry Foreign Trade
Detailed Import/Export Data by commodities and by countries
Mode of Shipment and insurance and freight costs
Industry Structure
Labor and Compensation Structure: productivity indices, hourly wages, production hours, output index, HR structure
Establishments: Trends, Employee Statistics, State by State numbers
Valued added statistics: industry GDP contribution
Competitive Landscape
Industry Concentration: HHI, number of companies, size distributions, market shares
Major Players: company profiles and market size ranges
__________________________________________
Definition & Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. This 6-digit NAICS industry (325413) is under the hierarchy of Pharmaceutical and Medicine Manufacturing Industry (32541), Chemical Manufacturing Subsector (325), and the Manufacturing Sector (31-33). Its SIC equivalent code is: 2835 - In Vitro and In Vivo Diagnostic Substances (in-vitro diagnostic substances).
Revenue, Profitability & Foreign Trade Preview
The industry's revenue for the year 2008 was approximately $13.4 billion USD, with an estimated gross profit of 43.66%. The industry used a projected 67 percent of its full production capacity in 2008. The industry could have increased its total shipment value to $20.1 billion USD under full production capacity. This industry did not have direct foreign trade statistics. The report nevertheless depicted relevant foreign trade data from a higher level NAICS industry or industry group.
Report Summary
This industry report contains 174 pages of in-depth market research with over 150 charts and tables. Industry sales and shipment data within the U.S. and its international trade are presented and forecasted. For financial analysis, the report presents industry level income statements, balance sheets, and capital expenditure figures. In the cost analysis section, 43 upstream industries are analyzed to offer insight into the supply chain cost structure. For the channel and pricing structure, 17 downstream industries are analyzed. The competitive landscape section provides the number of companies and their respective revenue share, the market concentration, and a list of major players. At a more granular level, products within the industry are listed with their respective market sizes and import and export data. The appendices contain relevant references to additional trade statistics, U.S. State statistics, and industry trade associations.
Our clients include Fortune 500 companies, manufacturers, international top consulting firms, major retailers and wholesalers, professional trade associations, financial corporations, universities, governmental entities, start-ups and individuals. We are committed to providing the highest level of quality to all our clients and assure your satisfaction in the report delivering as promised.
Related industries
reportlinker.com © Copyright 2009. All rights reserved